190 related articles for article (PubMed ID: 31413078)
21. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
[TBL] [Abstract][Full Text] [Related]
22. Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
Porwancher R; Landsberg L
PLoS One; 2021; 16(9):e0253514. PubMed ID: 34499659
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests.
Goossens HA; Maes JH; van den Bogaard AE
Tijdschr Diergeneeskd; 2003 Nov; 128(21):650-7. PubMed ID: 14650723
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a Novel Microarray Immunoblot Assay for Detection of IgM- and IgG-Class Antibodies to Borrelia burgdorferi.
Theel ES; Sorenson M; Granger D
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135227
[TBL] [Abstract][Full Text] [Related]
25. Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context.
Can Commun Dis Rep; 2020 May; 46(5):125-131. PubMed ID: 32558809
[TBL] [Abstract][Full Text] [Related]
26. Serodiagnosis of neuroborreliosis: comparison of reliability of three confirmatory assays.
Kaiser R; Rauer S
Infection; 1999; 27(3):177-82. PubMed ID: 10378128
[TBL] [Abstract][Full Text] [Related]
27. Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE/C6 ELISA and Immunoblot.
Riesbeck K; Hammas B
Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):517-9. PubMed ID: 17558488
[No Abstract] [Full Text] [Related]
28. Serum antibodies against Borrelia afzelii, Borrelia burgdorferi sensu stricto and the 41-kiloDalton flagellin in patients from a Lyme borreliosis endemic area: analysis by EIA and immunoblot.
Nilsson I; von Rosen IA
APMIS; 1996 Dec; 104(12):907-14. PubMed ID: 9048870
[TBL] [Abstract][Full Text] [Related]
29. Advantage of recombinant borrelial proteins for serodiagnosis of neuroborreliosis.
Kaiser R; Rauer S
J Med Microbiol; 1999 Jan; 48(1):5-10. PubMed ID: 9920119
[TBL] [Abstract][Full Text] [Related]
30. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
31. Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.
Lahey LJ; Panas MW; Mao R; Delanoy M; Flanagan JJ; Binder SR; Rebman AW; Montoya JG; Soloski MJ; Steere AC; Dattwyler RJ; Arnaboldi PM; Aucott JN; Robinson WH
J Clin Microbiol; 2015 Dec; 53(12):3834-41. PubMed ID: 26447113
[TBL] [Abstract][Full Text] [Related]
32. Retrospective validation of a rapid Lyme fluorescent immunoassay in differentiating Lyme arthritis from other musculoskeletal presentations in children in a Lyme-endemic region.
Donovan A; Quilty R; Joy BK; Seddigh S; Coatsworth H; Gauthier L; Comeau JL; Lang B; Leblanc J; Hatchette T; Stringer E
Microbiol Spectr; 2024 Jun; 12(6):e0359323. PubMed ID: 38682930
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.
Brandt KS; Ullmann AJ; Molins CR; Horiuchi K; Biggerstaff BJ; Gilmore RD
Diagn Microbiol Infect Dis; 2019 Mar; 93(3):196-202. PubMed ID: 30344068
[TBL] [Abstract][Full Text] [Related]
34. Simple objective detection of human lyme disease infection using immuno-PCR and a single recombinant hybrid antigen.
Halpern MD; Molins CR; Schriefer M; Jewett MW
Clin Vaccine Immunol; 2014 Aug; 21(8):1094-105. PubMed ID: 24899074
[TBL] [Abstract][Full Text] [Related]
35. Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers.
Marques AR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898997
[TBL] [Abstract][Full Text] [Related]
36. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre.
Bernard A; Kodjikian L; Abukhashabh A; Roure-Sobas C; Boibieux A; Denis P; Broussolle C; Seve P
Br J Ophthalmol; 2018 Mar; 102(3):369-372. PubMed ID: 28659389
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Testing for Lyme Disease.
Kobayashi T; Auwaerter PG
Infect Dis Clin North Am; 2022 Sep; 36(3):605-620. PubMed ID: 36116838
[TBL] [Abstract][Full Text] [Related]
39. A comparison of lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment.
Fallon BA; Pavlicova M; Coffino SW; Brenner C
Clin Infect Dis; 2014 Dec; 59(12):1705-10. PubMed ID: 25182244
[TBL] [Abstract][Full Text] [Related]
40. Higher Sensitivity of the
Kadkhoda K; Gretchen A
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29875190
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
